Semnur Pharmaceuticals Stock Price, News & Analysis
Company Description
Semnur Pharmaceuticals (OTC Link: SMNR) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $80.6M.
SMNR stock has declined 98.3% over the past year. Shares last traded at $0.3500.
On a trailing twelve-month basis, Semnur Pharmaceuticals and diluted earnings per share of $-0.78.
This page provides a comprehensive overview of SMNR stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Semnur Pharmaceuticals (SMNR) stock last traded at $0.3500. Over the past 12 months, the stock has lost 98.3%. At a market capitalization of $80.6M, SMNR is classified as a micro-cap stock with approximately 230.2M shares outstanding.
Latest News
SEC Filings
Semnur Pharmaceuticals has filed 5 recent SEC filings, including 1 Form EFFECT, 1 Form 10-Q, 1 Form POS AM, 1 Form ARS. The most recent filing was submitted on May 19, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all SMNR SEC filings →
Financial Highlights
Diluted earnings per share stood at $-0.78. The company generated -$5.9M in operating cash flow. With a current ratio of 0.06, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Short interest in Semnur Pharmaceuticals (SMNR) currently stands at 1.6 thousand shares, representing 0.0% of the shares outstanding.
Days to Cover History
Days to cover for Semnur Pharmaceuticals (SMNR) currently stands at 3.5 days, down 69% from the previous period. This days-to-cover ratio represents a balanced liquidity scenario for short positions. The days to cover has decreased 64.5% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 3.5 to 1000.0 days.
SMNR Company Profile & Sector Positioning
Semnur Pharmaceuticals (SMNR) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.